1043 Intratumoral mRNA IL-12 can induce a dose dependent immunostimulatory effect within tumor microenvironment in patients with advanced solid tumors
Abadier, Michael, Chow, Jacky, Van, Linh, Sehgal, Vasudha, Feldman, Igor, Do, Khanh, Aanur, Praveen, Durham, Nicholas, Chen, Xiaoru, Wu, Yuling, Fraenkel, Paula G, Azaro, Analia, Alvarez, Eduardo Castanon, Zamarin, Dmitriy, Carneiro, Benedito, Marron, Thomas, Patel, Sandip P, Subbiah, Vivek, Mehmi, Inderjit, Oberoi, Arjun, El-Khoueiry, Anthony, Hamid, Omid
Published in Journal for immunotherapy of cancer (01.11.2023)
Published in Journal for immunotherapy of cancer (01.11.2023)
Get full text
Journal Article
1530 T-cell responses to individualized neoantigen therapy (INT) mRNA-4157 (V940) as monotherapy or in combination with pembrolizumab
Gainor, Justin F, Patel, Manish R, Weber, Jeffrey, Gutierrez, Martin, Bauman, Julie E, Clarke, Jeffrey M, Julian, Ricklie A, Scott, Aaron J, Geiger, Jessica L, Kirtane, Kedar, Robert-Tissot, Celine, Coder, Brandon, Tasneem, Moomal, Sun, Jing, Zheng, Wei, Gerbereux, Lauren, Laino, Andressa, Pollard, Jack, Hou, Peijie, Sehgal, Vasudha, Daghestani, Hikmat N, Feldman, Igor, Srinivasan, Lakshmi, Frederick, Joshua, Brown, Michelle, Aanur, Praveen, Meehan, Robert, Burris, Howard A
Published in Journal for immunotherapy of cancer (01.11.2023)
Published in Journal for immunotherapy of cancer (01.11.2023)
Get full text
Journal Article
First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): a multicentre, randomised, open-label, phase 3 trial
Baas, Paul, Scherpereel, Arnaud, Nowak, Anna K, Fujimoto, Nobukazu, Peters, Solange, Tsao, Anne S, Mansfield, Aaron S, Popat, Sanjay, Jahan, Thierry, Antonia, Scott, Oulkhouir, Youssef, Bautista, Yolanda, Cornelissen, Robin, Greillier, Laurent, Grossi, Francesco, Kowalski, Dariusz, Rodríguez-Cid, Jerónimo, Aanur, Praveen, Oukessou, Abderrahim, Baudelet, Christine, Zalcman, Gérard
Published in The Lancet (British edition) (30.01.2021)
Published in The Lancet (British edition) (30.01.2021)
Get full text
Journal Article
Strategies for successful dose optimization in oncology drug development: a practical guide
Deng, Qiqi, Zhu, Lili, Weiss, Brendan, Aanur, Praveen, Gao, Lei
Published in Journal of biopharmaceutical statistics (11.08.2024)
Published in Journal of biopharmaceutical statistics (11.08.2024)
Get full text
Journal Article
Individualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): a randomised, phase 2b study
Weber, Jeffrey S, Carlino, Matteo S, Khattak, Adnan, Meniawy, Tarek, Ansstas, George, Taylor, Matthew H, Kim, Kevin B, McKean, Meredith, Long, Georgina V, Sullivan, Ryan J, Faries, Mark, Tran, Thuy T, Cowey, C Lance, Pecora, Andrew, Shaheen, Montaser, Segar, Jennifer, Medina, Theresa, Atkinson, Victoria, Gibney, Geoffrey T, Luke, Jason J, Thomas, Sajeve, Buchbinder, Elizabeth I, Healy, Jane A, Huang, Mo, Morrissey, Manju, Feldman, Igor, Sehgal, Vasudha, Robert-Tissot, Celine, Hou, Peijie, Zhu, Lili, Brown, Michelle, Aanur, Praveen, Meehan, Robert S, Zaks, Tal
Published in The Lancet (British edition) (17.02.2024)
Published in The Lancet (British edition) (17.02.2024)
Get full text
Journal Article
OX40 Agonist BMS-986178 Alone or in Combination With Nivolumab and/or Ipilimumab in Patients With Advanced Solid Tumors
Gutierrez, Martin, Moreno, Victor, Heinhuis, Kimberley M, Olszanski, Anthony J, Spreafico, Anna, Ong, Michael, Chu, Quincy, Carvajal, Richard D, Trigo, José, Ochoa de Olza, Maria, Provencio, Mariano, De Vos, Filip Yves, De Braud, Filippo, Leong, Stephen, Lathers, Deanne, Wang, Rui, Ravindran, Palani, Feng, Yan, Aanur, Praveen, Melero, Ignacio
Published in Clinical cancer research (15.01.2021)
Published in Clinical cancer research (15.01.2021)
Get full text
Journal Article
An Integrative Approach to Inform Optimal Administration of OX40 Agonist Antibodies in Patients with Advanced Solid Tumors
Wang, Rui, Gao, Chan, Raymond, Megan, Dito, Gennaro, Kabbabe, Dominic, Shao, Xiao, Hilt, Ed, Sun, Yongliang, Pak, Irene, Gutierrez, Martin, Melero, Ignacio, Spreafico, Anna, Carvajal, Richard D, Ong, Michael, Olszanski, Anthony J, Milburn, Christina, Thudium, Kent, Yang, Zheng, Feng, Yan, Fracasso, Paula M, Korman, Alan J, Aanur, Praveen, Huang, Shih-Min A, Quigley, Michael
Published in Clinical cancer research (15.11.2019)
Published in Clinical cancer research (15.11.2019)
Get full text
Journal Article
Minimal residual disease by circulating tumor DNA as a biomarker of recurrence free survival in resected high-risk melanoma patients treated with mRNA-4157/V940, a personalized cancer vaccine, and pembrolizumab
Carlino, Matteo S., Khattak, Adnan, Weber, Jeffrey S., Meniawy, Tarek, Sullivan, Ryan J., Taylor, Matthew H., Kim, Kevin B., McKean, Meredith, Faries, Mark B, Cowey, Charles Lance, Gibney, Geoffrey Thomas, Luke, Jason J., Thomas, Sajeve Samuel, Sehgal, Vasudha, Feldman, Igor, Aanur, Praveen, Brown, Michelle, Meehan, Robert S., Robert-Tissot, Celine, Long, Georgina V.
Published in Journal of clinical oncology (10.06.2023)
Published in Journal of clinical oncology (10.06.2023)
Get full text
Journal Article
T Cell Responses to Individualized Neoantigen Therapy mRNA-4157 (V940) Alone or in Combination With Pembrolizumab in the Phase 1 KEYNOTE-603 Study
Gainor, Justin F, Patel, Manish R, Weber, Jeffrey S, Gutierrez, Martin, Bauman, Julie E, Clarke, Jeffrey M, Julian, Ricklie, Scott, Aaron J, Geiger, Jessica L, Kirtane, Kedar, Robert-Tissot, Celine, Coder, Brandon, Tasneem, Moomal, Sun, Jing, Zheng, Wei, Gerbereux, Lauren, Laino, Andressa, Porichis, Filippos, Russella Pollard, Jack, Hou, Peijie, Sehgal, Vasudha, Chen, Xing, Morrissey, Manju, Daghestani, Hikmat N, Feldman, Igor, Srinivasan, Lakshmi, Frederick, Joshua P, Brown, Michelle, Aanur, Praveen, Meehan, Robert, Burris, Howard A
Published in Cancer discovery (08.08.2024)
Published in Cancer discovery (08.08.2024)
Get full text
Journal Article
First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): a multicentre, randomised, open-label, phase 3 trial
Baas, Paul, Scherpereel, Arnaud, Nowak, Anna, Fujimoto, Nobukazu, Peters, Solange, Tsao, Anne, Mansfield, Aaron, Popat, Sanjay, Jahan, Thierry, Antonia, Scott, Oulkhouir, Youssef, Bautista, Yolanda, Cornelissen, Robin, Greillier, Laurent, Grossi, Francesco, Kowalski, Dariusz, Rodríguez-Cid, Jerónimo, Aanur, Praveen, Oukessou, Abderrahim, Baudelet, Christine, Zalcman, Gérard
Published in The Lancet (British edition) (01.01.2021)
Published in The Lancet (British edition) (01.01.2021)
Get full text
Journal Article
FRACTION (Fast Real-time Assessment of Combination Therapies in Immuno-Oncology)-gastric cancer (GC): A randomized, open-label, adaptive, phase 2 study of nivolumab in combination with other immuno-oncology (IO) agents in patients with advanced GC
Aanur, Praveen, Gutierrez, Martin, Kelly, Ronan Joseph, Ajani, Jaffer A., Ku, Geoffrey Yuyat, Denlinger, Crystal Shereen, George, Thomas J., Wind-Rotolo, Megan, Guan, Xiaowei, Gupta, Manish, Reilly, Timothy P., Fracasso, Paula M.
Published in Journal of clinical oncology (20.05.2017)
Published in Journal of clinical oncology (20.05.2017)
Get full text
Journal Article
Abstract LB-127: From bench to bedside: Exploring OX40 receptor modulation in a phase 1/2a study of the OX40 costimulatory agonist BMS-986178 ± nivolumab (NIVO) or ipilimumab (IPI) in patients with advanced solid tumors
Wang, Rui, Feng, Yan, Hilt, Ed, Yuan, Xiling, Gao, Chan, Shao, Xiao, Sun, Yongliang, D'silva, Michael, Yang, Katherine, Penhallow, Becky, Bogdanoski, Goce, Anand, Rajesh, Pak, Irene, Greenawalt, Danielle, Klippel, Anke, Manjarrez-Orduno, Nataly, Neely, Robert, Quigley, Michael, Hedrick, Michael, Aanur, Praveen, Cao, Z
Published in Cancer research (Chicago, Ill.) (01.07.2018)
Published in Cancer research (Chicago, Ill.) (01.07.2018)
Get full text
Journal Article
Abstract CT141: mRNA-4157 (V940) individualized neoantigen therapy (INT) + pembrolizumab (pembro) in advanced unresectable HPV- head & neck carcinoma (HNSCC): Clinical & translational analysis
Bauman, Julie E., Julian, Ricklie A., Geiger, Jessica L., Mehnert, Janice M., Clarke, Jeffrey M., Patel, Manish R., Gutierrez, Martin, Gainor, Justin F., Srivats, Shyam, Zhang, Zhaojie, Rao, Anjali, Sehgal, Vasudha, Hou, Peijie, Morrissey, Manju, Feldman, Igor, Srinivasan, Lakshmi, Aanur, Praveen, Brown, Michelle, Meehan, Robert S.
Published in Cancer research (Chicago, Ill.) (05.04.2024)
Published in Cancer research (Chicago, Ill.) (05.04.2024)
Get full text
Journal Article
Abstract 6552: Intratumoral (ITu) delivery of mRNA-2752 encoding human OX40L/IL-23/IL-36γ in combination with durvalumab induces an immunostimulatory effect within the tumor microenvironment (TME) of patients with advanced solid tumors
Abadier, Michael, Sullivan, Ryan J., Chow, Jacky, Sehgal, Vasudha, Sweis, Randy F., Daud, Adil, Shapira-Frommer, Ronnie, Perets, Ruth, Kummar, Shivaani, McKean, Meredith, Geva, Ravit, Patel, Manish R., Khattak, Adnan, Fernandez-Peñas, Pablo, Zacharek, Sima, Wahl, Natalia, Walker, Russell M., Van, Linh, Aanur, Praveen, Ward, Jim, Do, Khanh T., Long, Georgina V.
Published in Cancer research (Chicago, Ill.) (22.03.2024)
Published in Cancer research (Chicago, Ill.) (22.03.2024)
Get full text
Journal Article
767 Safety and preliminary efficacy of mRNA-2752, a lipid nanoparticle encapsulating mRNAs encoding human OX40L/IL-23/IL-36γ for intratumoral (ITu) injection, and durvalumab (IV) in TNBC, HNSCC, and melanoma
Olson, Daniel, Daud, Adil, Shapira-Frommer, Ronnie, Jimeno, Antonio, Reagan, Patrick, Kummar, Shivaani, Abdul-Karim, Raghad, Stemmer, Salomon, McKean, Meredith, Geva, Ravit, Perets, Ruth, Patel, Manish, Marron, Thomas, Gupta, Shilpa, Desai, Anupam, Weber, Jeffrey, Margolin, Kim, Park, Jong Chul, Zacharek, Sima, Andressa Sodre Laino, Frederick, Joshua, Milberg, Oleg, Zhu, Lili, Mody, Kinjal, Lopez, Natalia, Aanur, Praveen, Meehan, Robert, Johansen, Lisa, Lavoie, Sara, Do, Khanh, Sullivan, Ryan, Sweis, Randy
Published in Journal for immunotherapy of cancer (01.11.2022)
Published in Journal for immunotherapy of cancer (01.11.2022)
Get full text
Journal Article
OX40에 대한 항체 및 그의 용도
HUANG CHRISTINE, SELBY MARK J, BARNHART BRYAN C, QUIGLEY MICHAEL, KEMPE THOMAS D, THUDIUM KENT, GUIRNALDA PATRICK, JURE KUNKEL MARIA, MAURER MARK, SRINIVASAN MOHAN, STEVENS BRENDA L, GARCIA MARIE MICHELLE NAVARRO, RODRIGUEZ MARIA, CHANG HAN, HAN MICHELLE MINHUA, WONG SUSAN CHIEN SZU, YANG ZHENG, FENG YAN, SHAO XIANG, AANUR PRAVEEN, CHAKRABORTY INDRANI, LEI MING, KOZHICH ALEXANDER T, HENNING KARLA A, KORMAN ALAN J, RAJPAL ARVIND, LONBERG NILS, LEMAR HADIA, YAMNIUK AARON P, SCHWEIZER LIANG, MILBURN CHRISTINA MARIA, CAI ZHEHONG, HATCHER SANDRA V, WANG XI TAO, GOKEMEIJER JO
Year of Publication 30.01.2018
Get full text
Year of Publication 30.01.2018
Patent